Literature DB >> 29230540

Preventing future fractures: effectiveness of an orthogeriatric fracture liaison service compared to an outpatient fracture liaison service and the standard management in patients with hip fracture.

Antonio Naranjo1,2, Sonia Fernández-Conde3, Soledad Ojeda4, Laura Torres-Hernández3, Carolina Hernández-Carballo3, Idoia Bernardos4, Sinforiano Rodríguez5, Pedro Laynez3.   

Abstract

An observational study was carried out in two hospitals in patients > 65 years admitted for hip fracture. At 6 months, 15% of patients in the hospital with orthogeriatric standard care and 75% in the hospital with fracture liaison service were receiving bisphosphonates.
PURPOSE: Many patients with fractures are discharged without preventive therapy against further fractures. We sought to compare the effectiveness of an orthogeriatric fracture liaison service (FLS), outpatient FLS, and the standard care after hip fractures in prevention of future fractures.
METHODS: An observational study was carried out in two hospitals in patients > 65 years of age, admitted between March and July 2016 for fractures. The Candelaria hospital (HUNSC) has no specific protocol for secondary prevention, while at the Negrin Hospital (HUGCDN), an FLS nurse visits the inpatients, gathers metabolic history, instructs regarding the diet, exercises, and fall prevention, and completes a discharge report regarding osteoporosis treatment. The prescription rate of osteoporosis treatment was analyzed at admission, discharge, and 6 months after discharge. We also analyzed the data of patients with hip fractures who attended the outpatient FLS before March 2016.
RESULTS: We included a total of 185 inpatients with a mean age of 82 years and 73% were women. At admission, 8% of the patients in HUNSC and 10% in HUGCDN were receiving bisphosphonates. At discharge, the percentages were 8 and 96%, while at 6 months they were 15 and 75%, respectively (p < 0.001). The outpatient FLS recorded 206 hip fractures (27% of discharges for fractures), with 77% adherence to treatment at 6 months.
CONCLUSIONS: Compared with the conventional management, the FLS model for inpatients with hip fractures achieved a fivefold increase in the adherence to treatment at 6 months, similar to the rates of outpatient FLS.

Entities:  

Keywords:  Fracture; Fracture liaison service; Hip; Orthogeriatric

Mesh:

Substances:

Year:  2017        PMID: 29230540     DOI: 10.1007/s11657-017-0373-9

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  6 in total

1.  Long-term persistence of treatment after hip fracture in a fracture liaison service.

Authors:  Antonio Naranjo; Amparo Molina; Adrián Quevedo; Francisco J Rubiño; Fernando Sánchez-Alonso; Carlos Rodríguez-Lozano; Soledad Ojeda
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

2.  Fracture liaison service model: treatment persistence 5 years later.

Authors:  Antonio Naranjo; Amparo Molina; Adrián Quevedo; Francisco J Rubiño; Fernando Sánchez-Alonso; Carlos Rodríguez-Lozano; Soledad Ojeda
Journal:  Arch Osteoporos       Date:  2021-04-04       Impact factor: 2.617

3.  Mobile Outreach: An Innovative Program for Older Orthopedic Patients in Care Facilities.

Authors:  Julie A Switzer; Lisa K Schroder
Journal:  Geriatr Orthop Surg Rehabil       Date:  2019-03-10

4.  Cost-Effectiveness Analysis of Fracture Liaison Services Compared with Standard of Care in the Secondary Prevention of Fragility Fractures in Spain.

Authors:  Antonio Naranjo; Daniel Prieto-Alhambra; Julián Sánchez-Martín; Alejandro Pérez-Mitru; Max Brosa
Journal:  Clinicoecon Outcomes Res       Date:  2022-04-22

5.  Minimizing Nonessential Follow-up for Hip Fracture Patients.

Authors:  Michael S Reich; Julie A Switzer; Andrew Sibley; Lisa K Schroder; Sandy Vang; Mai P Nguyen
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-06-02

Review 6.  Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends.

Authors:  K E Åkesson; K Ganda; C Deignan; M K Oates; A Volpert; K Brooks; D Lee; D R Dirschl; A J Singer
Journal:  Osteoporos Int       Date:  2022-03-24       Impact factor: 5.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.